Tag Archives: Marc Tessier-Lavigne
A physician-scientist widely recognized for uncovering the underlying causes of hypertension and other diseases, Lifton takes office on September 1. He replaces Marc Tessier-Lavigne, who left to lead Stanford University. More »
With a new imaging tool, scientists are able to measure the activity of all the neurons in a mouse brain with unmatched precision. The method is widely applicable for studying how the brain functions both under normal conditions and in disease. More »
With a new strategy they developed, Rockefeller scientists used the CRISPR genome editing system to engineer neurons so they looked like those in the brains of people suffering from Alzheimer’s disease. This development will aid biomedical research by making it easier to create cellular models of disease. More »
Scientists solve CRISPR’s ‘Energizer Bunny’ problem “‘It works beautifully,’ Tessier-Lavigne said. With standard CRISPR-Cas9, 6 percent to 35 percent of the edits were clean, without random insertions and deletions due to Cas9’s repeated cuts, but with their upgrade, the … More »
Scientists have long believed axons regulate their own pruning during development. But recent findings have challenged this assumption, and now scientists have proven that axons receive instructions from the cell body when its time to degenerate.
Marc Tessier-Lavigne, Ph.D., will step down from his position as president of The Rockefeller University September 1, 2016, to become the 11th president of Stanford University, it was announced today. More »
Will We Find a Cure for Cancer and Alzheimer’s Anytime Soon? “Science is on the march in the heart of New York City. With five Nobel Laureates on its faculty, Rockefeller University scientists are working to unlock the mysteries … More »
In the developing nervous system, some neurons must extend their branches to connect one half of the brain with the other. A new study sheds light on the molecular mechanisms that guide the winding paths of their axons. More »
Experiments show that a protein already implicated in degeneration, called Sarm1, functions to trigger the MAP kinase pathway. Inactivation of this pathway at any of three levels could block the death of damaged axons.
The annual recipient of the NY/NJ CEO Lifetime Achievement Award is nominated and elected by peers from within the biotechnology industry and it recognizes the extraordinary contributions of the awardees toward advancing medical science and products that address unmet medical needs, as well as in helping to create an environment that fosters the growth of the industry in the New York metropolitan area.
In a significant technical advance, a team of neuroscientists at The Rockefeller University has devised a fast, inexpensive imaging method for probing the molecular intricacies of large biological samples in three dimensions, an achievement that could have far reaching implications in a wide array of basic biological investigations. More »
Wanted: Biotech Startups in New York City “A lot of the legal and commercial groundwork has been established between Accelerator and its partner institutions, which should help speed the business-development process, said Marc Tessier-Lavigne, president of Rockefeller University.”
Rockefeller president joins U.S. university leaders in Israel to explore collaborative opportunities
Rockefeller’s president, Marc Tessier-Lavigne, will join several U.S. university leaders in Israel this week to explore opportunities for collaborations with Israeli institutions in areas such as brain science, environmental sustainability, biotechnology, diversity and women’s leadership. The visit has been arranged by Project Interchange, a non-profit educational institute of the American Jewish Committee, which is an advocacy group based in New York. More »
Tessier-Lavigne, Rockefeller president and head of the Laboratory of Brain Development, and Jeffrey M. Friedman head of the Laboratory of Molecular Genetics, were elected to the honorary society and independent policy research center along with 198 other leaders in science, art, academia and the civic, corporate and philanthropic arenas. The current membership includes some 250 Nobel laureates and more than 60 Pulitzer Prize winners, and 23 other Rockefeller University faculty members are fellows.
Friedman is being recognized for his groundbreaking discovery of leptin, a hormone that regulates food intake and energy expenditure. His observations provided scientists with a new target for treating obesity and other metabolic diseases.
President Marc Tessier-Lavigne will receive the Henry G. Friesen International Prize in Health Research, established by the Friends of Canadian Institutes of Health Research in collaboration with the Canadian Academy of Health Sciences to recognize exceptional innovation by a visionary health leader of international stature.
A world leader in the study of brain development, Tessier-Lavigne has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. Tessier-Lavigne is among 65 new members and five foreign associates elected to the Institute this year. More »
Marc Tessier-Lavigne, a leading neuroscientist and the former chief scientific officer of Genentech, takes over as president of The Rockefeller University today, replacing Paul Nurse, who has left to become president of the Royal Society in London. More »
The university’s Board of Trustees has elected Tessier-Lavigne to succeed Paul Nurse on March 11, 2011. A leader in the study of brain development, he is currently executive vice president for research and chief scientific officer at Genentech, one the world’s leading biotech companies. More »
For years, scientists have known that netrin molecules help guide growing neurons and their axons — the long tendrils that conduct electrical signals. But new research shows that these proteins are also important for helping create the neuron’s characteristically asymmetrical shape. More »